Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

Increase the proportion of sexually active female adolescents and young women who get screened for chlamydia — STI‑01

Status: Little or no detectable change

  
Image
Little or no detectable change

Most Recent Data:
53.4 percent (2022)

Target:
76.5 percent 1

Desired Direction:
Increase desired

Baseline:
54.9 percent of sexually active females aged 16 to 24 years enrolled in Medicaid and commercial health plans were screened for chlamydial infections, as reported in 2018 2

Increase the proportion of sexually active adolescent and young females enrolled in Medicaid and commercial health plans who are screened for chlamydial infections

Target-Setting Method
Maintain consistency with national programs, regulations, policies, or laws

Summary

Chlamydia is the most common bacterial sexually transmitted infection in the United States. Untreated chlamydia can cause pelvic inflammatory disease, infertility, and chronic pelvic pain in women. Chlamydia usually doesn’t cause symptoms, so yearly screening in sexually active females under 25 years is the most effective way to diagnose chlamydia and prevent complications.



1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.